USPTO Examiner SIMMONS VALERIE MICHELLE - Art Unit 1758

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19023978MXENE-LIGNIN COMPOSITE AND POWER-FREE CHEMICAL SENSOR INCLUDING THE SAME AS AN ACTIVE LAYERJanuary 2025September 2025Allow820YesNo
18821344COLORIMETRIC NANOSENSOR FOR DETECTING TRACE-LEVEL OF HG2+ IN ENVIRONMENTAL WATERAugust 2024November 2025Allow1420YesNo
17785517METHOD AND DEVICE FOR ANALYSIS OF LIQUID SAMPLESJune 2022October 2025Abandon4010NoNo
17778568METHOD FOR PREPARING CRYSTAL STRUCTURAL ANALYSIS SAMPLE FOR STRUCTURAL ANALYSIS OF NUCLEOPHILIC GROUP-CONTAINING COMPOUNDS BY CRYSTALLINE SPONGE METHODMay 2022March 2026Abandon4520YesNo
17778531PREPARATION METHOD OF CRYSTAL STRUCTURE ANALYSIS SAMPLE FOR STRUCTURAL ANALYSIS USING CRYSTAL SPONGE METHODMay 2022March 2026Abandon4520NoNo
17770440SPECTROPHOTOMETRIC SYSTEM AND METHOD FOR WIRELESS WATER QUALITY MANAGEMENT OF AQUACULTURE BASINApril 2022December 2025Allow4320YesNo
17720385ISOLATION AND CHARACTERIZATION OF PIGMENTS FROM CANNABISApril 2022September 2025Abandon4110NoNo
177546612-METHYLBUTYRATE, A BIOMARKER FOR IMPROVEMENTS OF MOOD DISORDERSApril 2022September 2025Abandon4210NoNo
17629176LIQUID SAMPLE TESTING DEVICEJanuary 2022December 2025Abandon4720NoNo
17597062DISTANCE MEASURING DEVICE AND METHOD FOR MEASURING DISTANCEDecember 2021December 2025Allow4720YesNo
17546339PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATIONDecember 2021August 2025Abandon4530NoNo
17507835DEVICE AND METHOD FOR LOCALISING OR IDENTIFYING MALIGNANCIESOctober 2021December 2024Abandon3810NoNo
17603873SENSOR BASED ON A POLYOLEFIN MATRIX AND A SENSING COMPOUNDOctober 2021May 2025Abandon4320NoNo
17594256Chemical Hydrogen Peroxide IndicatorOctober 2021May 2025Allow4310YesNo
17601189A SENSITIVE LC-MS ASSAY TO MEASURE CURCUMINOIDS IN COMPLEX BIOLOGICAL SAMPLESOctober 2021May 2025Abandon4310NoNo
17593997METHOD FOR THE DIAGNOSTIC AND/OR PROGNOSTIC ASSESSMENT OF ACUTE-ON-CHRONIC LIVER FAILURE SYNDROME IN PATIENTS WITH LIVER DISORDERSSeptember 2021January 2025Abandon3910NoNo
17478028CONTAINER AND KIT FOR PREPARING CELL CULTURE IN HIGH-CLEANLINESS SPACESeptember 2021February 2026Abandon5331NoNo
17463666METHOD FOR FUNCTIONAL CHARACTERISTICS OF PROTEINS FOR CLASSIFICATION OF PATIENTS TO BE ASSOCIATED TO A SPECIFIC DISEASESeptember 2021March 2026Abandon5420YesNo
17461958METHOD OF PREVENTING DAMAGE OCCURRING IN MICROBIAL AEROSOLIZATION PROCESSAugust 2021February 2025Abandon4210NoNo
17459257DETECTION OF POLYMER SHALE ENCAPSULATORS IN WELLBORE FLUIDAugust 2021January 2026Abandon5240YesNo
17412955BLOOD EXAMINATION KIT AND METHOD OF SEPARATING PLASMA OR SERUMAugust 2021January 2026Abandon5231YesNo
17444467Portable Cannabidiol Testing DeviceAugust 2021October 2025Abandon5121NoNo
17426444METHOD FOR INSPECTING REFRIGERANT PIPE AND REFRIGERANT PIPEJuly 2021June 2025Abandon4721NoNo
17423996GAS AND/OR CHEMICAL LIQUID INDICATORJuly 2021October 2024Abandon3910NoNo
17378009SAMPLE PREPARATION AND TEST METHODS FOR DIAGNOSING CHRONIC WASTING DISEASEJuly 2021January 2025Abandon4220NoNo
17305473DETERMINATION METHOD AND TREATMENT METHODJuly 2021May 2025Allow4621YesNo
17357105MONITORING WELLBORE FLUIDS USING METAL IONS FROM TRACERSJune 2021January 2026Allow5541YesNo
17350426TECHNIQUES FOR PERFORMING OPTICAL AND ELECTROCHEMICAL ASSAYS WITH UNIVERSAL CIRCUITRYJune 2021November 2025Allow5311NoNo
17343037METHOD FOR ANALYZING A PARTICLE ACCUMULATION ON A MEMBRANE, DEVICE FOR AUTOMATED ANALYSIS, AND SAMPLE-PREPARATION UNIT THEREFORJune 2021September 2025Abandon5221NoNo
17338950METHOD FOR RAPID DETECTION OF DRY EYE SYNDROMEJune 2021February 2025Abandon4520NoNo
17298502HIGH/HYPERVELOCITY PARTICLE CAPTURE AND ANALYSIS METHOD AND APPARATUSMay 2021October 2024Abandon4001NoNo
17273306METHOD FOR MEASURING THE CONTAMINATION OF DRINKING WATER BY MICRO-ORGANISMS, IN A DRINKING WATER CONDUITMay 2021January 2025Abandon4720NoNo
17297128METHOD FOR DETERMINING THE SENSITIVITY TO OXIDATION OF A BITUMINOUS BINDER BY ELECTRON SPIN RESONANCEMay 2021October 2025Abandon5320NoNo
17229086DETERMINING A QUANTITY OF AN ANALYTE IN A BLOOD SAMPLEApril 2021September 2024Allow4120NoNo
17282289METHOD FOR THE DETERMINATION OF PROTEIN S LEVELSApril 2021August 2024Abandon4101NoNo
17281857A METHOD FOR DETERMINING CONCENTRATION OF PHOSPHATEMarch 2021August 2024Abandon4110NoNo
17280210A method of selectively catalytically oxidizing dinitrogen oxide, a method of detecting radiocarbon, an apparatus, and use of a NiO catalystMarch 2021October 2024Allow4211NoNo
17200746GASOTRANSMITTER METABOLITES AND ALZHEIMER'S DISEASEMarch 2021December 2024Allow4511YesNo
17274331HIGH SPEED MODULATION SAMPLE IMAGING APPARATUS AND METHODMarch 2021February 2026Abandon5940NoNo
17170439GRAPHENE-BASED SENSOR FOR DETECTING HEMOGLOBIN IN A BIOLOGICAL SAMPLEFebruary 2021July 2025Abandon5321NoNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner SIMMONS, VALERIE MICHELLE - Prosecution Strategy Guide

Executive Summary

Examiner SIMMONS, VALERIE MICHELLE works in Art Unit 1758 and has examined 31 patent applications in our dataset. With an allowance rate of 25.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 45 months.

Allowance Patterns

Examiner SIMMONS, VALERIE MICHELLE's allowance rate of 25.8% places them in the 3% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by SIMMONS, VALERIE MICHELLE receive 1.84 office actions before reaching final disposition. This places the examiner in the 43% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SIMMONS, VALERIE MICHELLE is 45 months. This places the examiner in the 12% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +49.5% benefit to allowance rate for applications examined by SIMMONS, VALERIE MICHELLE. This interview benefit is in the 93% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 22.2% of applications are subsequently allowed. This success rate is in the 28% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 0% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Petition Practice

When applicants file petitions regarding this examiner's actions, 133.3% are granted (fully or in part). This grant rate is in the 96% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 6% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 6% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.